SynthesisClinical rheumatology2019

Adverse drug events associated with 5mg versus 10mg Tofacitinib (Janus kinase inhibitor) twice daily for the treatment of autoimmune diseases: A systematic review and meta-analysis of randomized controlled trials.

Feng Huang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.